Research Articles | Page 26 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy Jun 2023 Haematologica Aplastic Anemia
Treatment of lower-risk myelodysplastic syndromes Oct 2024 Haematologica Myelodysplastic Syndromes (MDS)
Treatment of lower-risk myelodysplastic syndromes Feb 2025 Haematologica Myelodysplastic Syndromes (MDS)
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia Apr 2024 Haematologica Aplastic Anemia
Treatment of high-risk myelodysplastic syndromes Feb 2025 Haematologica Myelodysplastic Syndromes (MDS)
Diagnosis of myelodysplastic syndromes: the classic and the novel Feb 2025 Haematologica Myelodysplastic Syndromes (MDS)
Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria Aug 2023 Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)
Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria Oct 2020 Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)
Genome sequencing in the management of myelodysplastic syndromes and related disorders Feb 2025 Haematologica Myelodysplastic Syndromes (MDS)
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia Aug 2024 Haematologica Aplastic Anemia